Stem Cell Research

CRYO-CELL announces acquisition by affiliate, CRYO-CELL Europe

Published in Gene Therapy Weekly, July 4th, 2002

Cryo-Cell International, Inc. (CCEL) announced that its affiliate, Cryo-Cell Europe, N.V., Zutphen, the Netherlands has completed the acquisition of MainGen GmbH from Asta Medica AG, a subsidiary of Degussa AG.

MainGen, located in Frankfurt, Germany, is a licensed GMP clean room facility that specializes in the processing, preparation, and expansion of adult stem cells from cord blood and bone marrow for clinical applications in university and research hospitals. In addition, MainGen has developed techniques for in vitro transduction of CD-34 cells for use in gene therapy. CRYO-CELL Europe intends to redesign the MainGen facility to increase the capacity of cord blood...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-07-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry